Macleods Pharma IPO

It is pharmaceutical company, engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including antiinfectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment.

Macleods Pharma IPO Details

Check out the issue details for Macleods Pharma IPO as disclosed in SEBI.

Price Band

Not Issued

Issue Size

Not Issued

Issue Type

Book Built

Open

Not Issued

Close

Not Issued

Macleods Pharma News

 IPO news not found.

Company Financials

You can get the following financial statements of Macleods Pharma as of now.

Company Name

Macleods Pharma

  Profit Loss
  Balance Sheet
  Quarterly
  Shareholding
  Cash Flow

Macleods Pharmaceuticals IPO Valuation

The approx valuation of Macleods Pharmaceuticals IPO company based on its price band and DRHP (prospectus) is: 

Particulars Value
Upper Price Band Rs __
Existing Shares (Qty) 59.88 Cr
EPS (FY21) Rs 33.74
Industry PE 32.53x

 

Macleods Pharmaceuticals IPO Issue Size

Macleods Pharmaceuticals IPO issue size is not disclosed. 

Issue Amount
Fresh Issue 0 Cr
Offer For Sale (Qty) 6.04 Cr

 

Macleods Pharmaceuticals IPO Market Lot

An Individual can apply for a minimum 1 lot of _ shares and a maximum of 13 lots of _ shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 _ Rs _
 Maximum 13 _ Rs _

 

Macleods Pharmaceuticals IPO share offer

The category-wise shares offered are as follows:

Category % Offered
Qualified Institutional Maximum 50%
Non-Institutional Minimum 15%
Retail Individual Minimum 35%

 

The dates for the IPO is not been disclosed. 

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 6076.16 6590.5 7014.11 7462.67 7813.3
Total Expenditure 4736.76 4686.17 4670.54 5903.28 6381.99
Operating Profit 1339.4 1904.32 2343.56 1559.38 1431.31
Other Income 223.12 329.95 544.64 125.82 213.34
Interest 8.27 19.15 5.84 10.81 7.43
Depreciation 90.21 94.63 132.13 156.55 169.85
Exceptional Items 0 0 0 0 0
Profit Before Tax 1464.04 2120.5 2750.23 1517.84 1467.37
Provision for Tax 182.32 265.26 533.91 350.61 -8.02
Net Profit 1281.73 1855.24 2216.33 1167.23 1475.39
Adjusted EPS (Rs.) 2.14 3.1 3.7 1.95 2.46

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 19.96 19.96 19.96 59.88 59.88
Total Reserves 6257.37 8072.73 4226.69 5353.38 6840.29
Borrowings 0 31.82 0 0 0
Other N/C liabilities 213.54 223.38 -356.33 -298.23 -542.95
Current liabilities 882.89 1048.58 1428.64 1324.91 1537.23
Total Liabilities 7373.77 9396.47 5318.96 6439.94 7894.45
Assets
Net Block 1074.44 1245.48 1399.64 1473.42 1618.99
Capital WIP 51.15 213.55 252.75 334.34 189.93
Intangible WIP 0 0 0 0 0
Investments 1111.59 1168.58 16.93 234.76 438.53
Loans & Advances 32.68 33.36 123.88 89.94 89.96
Other N/C Assets 297.27 2104.22 220.6 771.75 546.2
Current Assets 4806.63 4631.28 3305.17 3535.73 5010.85
Total Assets 7373.77 9396.47 5318.96 6439.94 7894.45
* Other Non-current Liabilities include Net deferred Liabilities

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2021 100 0
Mar 2020 100 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023
Profit from operations 1517.84 1467.37
Adjustment 113.05 98.35
Changes in Assets & Liabilities 95.14 664.11
Tax Paid -314.77 -228.77
Operating Cash Flow 1411.25 2001.06
Investing Cash Flow -1400.17 -2067.06
Financing Cash Flow -21.12 95.36
Net Cash Flow -10.04 29.36
X